APTUSBIOTECH

AptusBiotech is a biotech company with a pipeline focused on researching novel antitumor therapies based on aptamer technology. But AptusBiotech is also a service company where we make all of our experience available to our clients to apply it to the development and application of aptamers in their specific applications: diagnostic, therapeutic or biotechnological... AptusBiotech is developing a therapeutic aptamer against MNK1b (apMNKQ2) that i) inhibits tumorigenesis, affecting proliferation and the ability to form colonies in three breast tumor lines; ii) it produces cell death, mainly through a caspase-mediated apoptotic mechanism; iii) inhibits the metastatic capacity of breast tumor cells, altering the epithelium-mesenchyme transition (TEM) and inhibiting cell migration and invasion.

Primary location: Madrid Spain